DR info

Clinical trials : 116 / Drugs : 65 - (DrugBank : 17) / Drug target genes : 50 - Drug target pathways : 64

Dorabe syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
140	Dorabe syndrome
6	Parkinson disease
144	Lennox-Gastaut syndrome
156	Rett syndrome
2	Amyotrophic lateral sclerosis
13	Multiple sclerosis/Neuromyelitis optica
97	Ulcerative colitis
193	Prader-Willi syndrome
8	Huntington disease
17	Multiple system atrophy
206	Fragile X syndrome
201	Angelman syndrome
298	Hereditary pancreatitis
18	Spinocerebellar degeneration
5	Progressive supranuclear palsy
145	West syndrome
70	Spinal stenosis
3	Spinal muscular atrophy
272	Fibrodysplasia ossificans progressiva
96	Crohn disease
36	Epidermolysis bullosa
231	Alpha-1-antitrypsin deficiency
152	PCDH19 related syndrome
46	Malignant rheumatoid arthritis
155	Acquired aphasia with convulsive disorder
158	Tuberous sclerosis
84	Sarcoidosis
205	Fragile X syndrome related disease
34	Neurofibromatosis
22	Moyamoya disease
21	Mitochondrial disease
98	Eosinophilic gastrointestinal disease
296	Biliary atresia
75	Cushing disease
203	22q11.2 deletion syndrome
86	Pulmonary arterial hypertension
90	Retinitis pigmentosa
226	Interstitial cystitis with Hunners ulcer
51	Scleroderma
114	Non-dystrophic myotonia syndrome
58	Hypertrophic cardiomyopathy
7	Corticobasal degeneration
168	Ehlers-Danlos syndrome
1	Spinal and bulbar muscular atrophy
149	Hemiconvulsion hemiplegia epilepsy syndrome
10	Charcot-Marie-Tooth disease
4	Primary lateral sclerosis
309	Progressive myoclonus epilepsy
127	Frontotemporal lobar degeneration
38	Stevens-Johnson syndrome
74	Prolactin secreting pituitary adenoma
167	Marfan syndrome
164	Oculocutaneous albinism
81	Congenital adrenal hyperplasia
299	Cystic fibrosis
187	Kabuki syndrome
256	Muscle glycogenosis
179	Williams syndrome
254	Porphyria